Center for Global Health R&D Policy Assessment

Follow us on:

Read our detailed commentary on BVGH's milestone-based prize for point-of-care fever diagnostics. We highlight several strengths in the design of the incentive while raising important questions.

Our newest assessment explores whether tax credits would encourage large biotechnology and pharmaceutical firms in the United States to increase investments in global health research.

The consultation draft of our new assessment, "Patent Pools: Assessing Their Value-Added for Global Health Innovation and Access" is now available for your review and comments. Your feedback is welcome and highly valued.

From across the globe, new proposals are surfacing to speed up the development of medical technologies for the world’s poorest countries. Visit our Idea Browser to explore current policy proposals.

Billions of people in the developing world suffer from diseases that mainstream R&D overlooks. New policy ideas to create incentives and address other barriers are emerging – along with a need for deep analysis.

We provide assessments of innovative policy proposals so that the best ideas flourish and produce the drugs, vaccines and diagnostics needed for the poor.

Signup for email updates

Featured Blog Post

Posted by Aarthi Rao

Dec 14 2011

Learning from the Success of Global Immunization

Reflections on the CSIS "Conference on the Strategic Power of Vaccines" Event

With the Gates Foundation’s effort to turn the next ten years into a global “Decade of Vaccines,” vaccines have taken center stage at a number of high level policy events. On Friday, the Center for Strategic and International Studies (CSIS) hosted the “Conference on the Strategic Power of Vaccines” which brought together top leaders such as Dr.

Featured Policy Innovations

New Innovation Fund

The New Innovation Fund aims to benefit local R&D in the pharmaceutical sector and to improve market competitiveness. This fund would be a national level fund for R&D focusing on orphan and neglected diseases that would require all beneficiaries to license their technologies to generic manufacturers.

The proponents pose two possibilities—the first offers innovators less...

Need help?

Looking for a page in particular? Our home page connects you to all of the main sections of our website. Scroll through the panel below to learn more about our project. The panels on the bottom of the page will take you to our blog and Policy Innovations page.

Center for Global Health R&D Policy Assessment

Follow us on:

Follow us on:

Featured Blog Post

Learning from the Success of Global Immunization

Reflections on the CSIS "Conference on the Strategic Power of Vaccines" Event

Recent Posts

Featured Policy Innovations

New Innovation Fund

Need help?